450 related articles for article (PubMed ID: 10344064)
1. Improved blood pressure control by monitoring compliance with antihypertensive therapy.
Waeber B; Vetter W; Darioli R; Keller U; Brunner HR
Int J Clin Pract; 1999; 53(1):37-8. PubMed ID: 10344064
[TBL] [Abstract][Full Text] [Related]
2. Patterns of compliance with once versus twice daily antihypertensive drug therapy in primary care: a randomized clinical trial using electronic monitoring.
Leenen FH; Wilson TW; Bolli P; Larochelle P; Myers M; Handa SP; Boileau G; Tanner J
Can J Cardiol; 1997 Oct; 13(10):914-20. PubMed ID: 9374947
[TBL] [Abstract][Full Text] [Related]
3. Benefits of electronic pillboxes in evaluating treatment compliance of patients with mild to moderate hypertension.
Mallion JM; Dutrey-Dupagne C; Vaur L; Genes N; Renault M; Elkik F; Baguet P; Boutelant S
J Hypertens; 1996 Jan; 14(1):137-44. PubMed ID: 12013487
[TBL] [Abstract][Full Text] [Related]
4. Shifting trends in the pharmacologic treatment of hypertension in a Nigerian tertiary hospital: a real-world evaluation of the efficacy, safety, rationality and pharmaco-economics of old and newer antihypertensive drugs.
Adigun AQ; Ishola DA; Akintomide AO; Ajayi AA
J Hum Hypertens; 2003 Apr; 17(4):277-85. PubMed ID: 12714973
[TBL] [Abstract][Full Text] [Related]
5. Medication adherence before an increase in antihypertensive therapy: a cohort study using pharmacy claims data.
Grant RW; Singer DE; Meigs JB
Clin Ther; 2005 Jun; 27(6):773-81. PubMed ID: 16117984
[TBL] [Abstract][Full Text] [Related]
6. Usefulness of the alpha1-blocker doxazosin as a third-line antihypertensive drug.
Ohta Y; Tsuchihashi T; Onaka U; Eto K; Ueno M
Hypertens Res; 2007 Apr; 30(4):301-6. PubMed ID: 17541208
[TBL] [Abstract][Full Text] [Related]
7. Eprosartan provides safe and effective long-term maintenance of blood pressure control in patients with mild to moderate essential hypertension.
Levine B
Curr Med Res Opin; 2001; 17(1):8-17. PubMed ID: 11464450
[TBL] [Abstract][Full Text] [Related]
8. Blood pressure control in patients initiating antihypertensive therapy.
Weycker D; Edelsberg J; Vincze G; Levy DG; Kartashov A; Oster G
Ann Pharmacother; 2008 Feb; 42(2):169-76. PubMed ID: 18182472
[TBL] [Abstract][Full Text] [Related]
9. [Arterial hypertension difficult to control in the elderly patient. The significance of the "white coat effect"].
Amado P; Vasconcelos N; Santos I; Almeida L; Nazaré J; Carmona J
Rev Port Cardiol; 1999 Oct; 18(10):897-906. PubMed ID: 10590654
[TBL] [Abstract][Full Text] [Related]
10. Monitoring one-year compliance to antihypertension medication in the Seychelles.
Bovet P; Burnier M; Madeleine G; Waeber B; Paccaud F
Bull World Health Organ; 2002; 80(1):33-9. PubMed ID: 11884971
[TBL] [Abstract][Full Text] [Related]
11. Impact of supportive measures on drug adherence in patients with essential hypertension treated with valsartan: the randomized, open-label, parallel group study VALIDATE.
Düsing R; Handrock R; Klebs S; Tousset E; Vrijens B
J Hypertens; 2009 Apr; 27(4):894-901. PubMed ID: 19300114
[TBL] [Abstract][Full Text] [Related]
12. Clinical experience in treating hypertension with fixed-dose combination therapy: angiotensin II receptor blocker losartan plus hydrochlorothiazide.
Abe M; Okada K; Matsumoto K
Expert Opin Drug Metab Toxicol; 2009 Oct; 5(10):1285-303. PubMed ID: 19761411
[TBL] [Abstract][Full Text] [Related]
13. Nurse management for hypertension. A systems approach.
Rudd P; Miller NH; Kaufman J; Kraemer HC; Bandura A; Greenwald G; Debusk RF
Am J Hypertens; 2004 Oct; 17(10):921-7. PubMed ID: 15485755
[TBL] [Abstract][Full Text] [Related]
14. Effect of pharmaceutical formulation for antihypertensive therapy on health service utilization.
Skaer TL; Sclar DA; Robison LM; Chin A; Gill MA; Okamoto MP; Nakahiro RK
Clin Ther; 1993; 15(4):715-25; discussion 714. PubMed ID: 8221822
[TBL] [Abstract][Full Text] [Related]
15. Compliance, electronic monitoring and antihypertensive drugs.
Mallion JM; Baguet JP; Siche JP; Tremel F; de Gaudemaris R
J Hypertens Suppl; 1998 Jan; 16(1):S75-9. PubMed ID: 9534102
[TBL] [Abstract][Full Text] [Related]
16. Impact of electronic monitoring of drug adherence on blood pressure control in primary care: a cluster 12-month randomised controlled study.
Santschi V; Rodondi N; Bugnon O; Burnier M
Eur J Intern Med; 2008 Oct; 19(6):427-34. PubMed ID: 18848176
[TBL] [Abstract][Full Text] [Related]
17. Compliance and blood pressure control in women with hypertension.
Bobb-Liverpool B; Duff EM; Bailey EY
West Indian Med J; 2002 Dec; 51(4):236-40. PubMed ID: 12632640
[TBL] [Abstract][Full Text] [Related]
18. Additional antihypertensive effect of drugs in hypertensive subjects uncontrolled on diltiazem monotherapy: a randomized controlled trial using office and home blood pressure monitoring.
Karotsis AK; Symeonidis A; Mastorantonakis SE; Stergiou GS;
Clin Exp Hypertens; 2006 Oct; 28(7):655-62. PubMed ID: 17060064
[TBL] [Abstract][Full Text] [Related]
19. Antiproteinuric and blood pressure-lowering effects of a fixed-dose combination of losartan and hydrochlorothiazide in hypertensive patients with stage 3 chronic kidney disease.
Abe M; Okada K; Maruyama T; Matsumoto K
Pharmacotherapy; 2009 Sep; 29(9):1061-72. PubMed ID: 19698011
[TBL] [Abstract][Full Text] [Related]
20. Electronic monitoring of adherence as a tool to improve blood pressure control. A randomized controlled trial.
Wetzels GE; Nelemans PJ; Schouten JS; Dirksen CD; van der Weijden T; Stoffers HE; Janknegt R; de Leeuw PW; Prins MH
Am J Hypertens; 2007 Feb; 20(2):119-25. PubMed ID: 17261454
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
